Cochlear implant maker Med-El USA said today it won FDA approval for its Rondo 2 cochlear implant audio processor with an expected launch of the device this fall.
The Durham, N.C.-based ocmpany said the newly cleared Rondo 2 audio processor features wireless charging capabilities that allow the device to fully recharge in four hours after being placed onto a charging pad, and can provide 18 hours of battery life.
The system is designed to be worn off the ear and can connect to cell phones, televisions, Bluetooth neckloops and hearing induction loops, Med-EL said, and can be discreetly hidden under hair.
“Rondo 2 is the easiest to use CI audio processor ever made. And because MED-EL engineers every internal cochlear implant to be future-ready, all of our recipients will be able to enjoy the latest industry-leading audio processing technology,” Med-El NA prez & CEO Raymond Gamble said in a press release.
These featured panels at DeviceTalks Boston will explore the state of R&D at major medtech firms, as well as the latest trends when it comes to developing combination products, neuromodulation devices, robotic systems and women's health technology.
View Technology Track Featured Sessions
Register today to save. Use code TECHTRACK to save an additional 10%.